Logo image of BCO.DE

BOEING CO/THE (BCO.DE) Stock Fundamental Analysis

FRA:BCO - Deutsche Boerse Ag - US0970231058 - Common Stock - Currency: EUR

195.68  -2.8 (-1.41%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BCO. BCO was compared to 45 industry peers in the Aerospace & Defense industry. BCO may be in some trouble as it scores bad on both profitability and health. BCO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

BCO had negative earnings in the past year.
BCO had a negative operating cash flow in the past year.
In the past 5 years BCO always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: BCO reported negative operating cash flow in multiple years.
BCO.DE Yearly Net Income VS EBIT VS OCF VS FCFBCO.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

1.2 Ratios

BCO's Return On Assets of -7.45% is on the low side compared to the rest of the industry. BCO is outperformed by 84.44% of its industry peers.
Industry RankSector Rank
ROA -7.45%
ROE N/A
ROIC N/A
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BCO.DE Yearly ROA, ROE, ROICBCO.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BCO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BCO.DE Yearly Profit, Operating, Gross MarginsBCO.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1

2. Health

2.1 Basic Checks

BCO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BCO has more shares outstanding
The number of shares outstanding for BCO has been increased compared to 5 years ago.
Compared to 1 year ago, BCO has an improved debt to assets ratio.
BCO.DE Yearly Shares OutstandingBCO.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BCO.DE Yearly Total Debt VS Total AssetsBCO.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

Based on the Altman-Z score of 1.20, we must say that BCO is in the distress zone and has some risk of bankruptcy.
BCO has a worse Altman-Z score (1.20) than 84.44% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.2
ROIC/WACCN/A
WACC9.88%
BCO.DE Yearly LT Debt VS Equity VS FCFBCO.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

A Current Ratio of 1.23 indicates that BCO should not have too much problems paying its short term obligations.
BCO has a Current ratio of 1.23. This is comparable to the rest of the industry: BCO outperforms 51.11% of its industry peers.
A Quick Ratio of 0.37 indicates that BCO may have some problems paying its short term obligations.
The Quick ratio of BCO (0.37) is worse than 91.11% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.37
BCO.DE Yearly Current Assets VS Current LiabilitesBCO.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

3

3. Growth

3.1 Past

The earnings per share for BCO have decreased strongly by -247.36% in the last year.
Looking at the last year, BCO shows a decrease in Revenue. The Revenue has decreased by -9.15% in the last year.
BCO shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.74% yearly.
EPS 1Y (TTM)-247.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.64%
Revenue 1Y (TTM)-9.15%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%17.67%

3.2 Future

BCO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.17% yearly.
Based on estimates for the next years, BCO will show a quite strong growth in Revenue. The Revenue will grow by 14.30% on average per year.
EPS Next Y91.1%
EPS Next 2Y47.72%
EPS Next 3Y32.64%
EPS Next 5Y20.17%
Revenue Next Year25.38%
Revenue Next 2Y20.52%
Revenue Next 3Y17.13%
Revenue Next 5Y14.3%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BCO.DE Yearly Revenue VS EstimatesBCO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B
BCO.DE Yearly EPS VS EstimatesBCO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 -10 -20

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BCO. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 61.52, the valuation of BCO can be described as expensive.
Based on the Price/Forward Earnings ratio, BCO is valued expensively inside the industry as 80.00% of the companies are valued cheaper.
The average S&P500 Price/Forward Earnings ratio is at 35.34. BCO is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 61.52
BCO.DE Price Earnings VS Forward Price EarningsBCO.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BCO.DE Per share dataBCO.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

BCO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BCO's earnings are expected to grow with 32.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.72%
EPS Next 3Y32.64%

0

5. Dividend

5.1 Amount

BCO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BOEING CO/THE

FRA:BCO (7/16/2025, 5:27:28 PM)

195.68

-2.8 (-1.41%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)04-23 2025-04-23/bmo
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners74.46%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap147.54B
Analysts82.78
Price Target200.35 (2.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.94%
Min EPS beat(2)-91.07%
Max EPS beat(2)63.2%
EPS beat(4)2
Avg EPS beat(4)-16.75%
Min EPS beat(4)-91.07%
Max EPS beat(4)63.2%
EPS beat(8)5
Avg EPS beat(8)2.53%
EPS beat(12)5
Avg EPS beat(12)-793.15%
EPS beat(16)6
Avg EPS beat(16)-758.16%
Revenue beat(2)0
Avg Revenue beat(2)-5.7%
Min Revenue beat(2)-8.71%
Max Revenue beat(2)-2.69%
Revenue beat(4)0
Avg Revenue beat(4)-4.79%
Min Revenue beat(4)-8.71%
Max Revenue beat(4)-2.69%
Revenue beat(8)2
Avg Revenue beat(8)-2.15%
Revenue beat(12)2
Avg Revenue beat(12)-3.63%
Revenue beat(16)2
Avg Revenue beat(16)-5.09%
PT rev (1m)4.84%
PT rev (3m)5.73%
EPS NQ rev (1m)-25.68%
EPS NQ rev (3m)-75.98%
EPS NY rev (1m)-7.33%
EPS NY rev (3m)6.08%
Revenue NQ rev (1m)5.95%
Revenue NQ rev (3m)3.87%
Revenue NY rev (1m)1.16%
Revenue NY rev (3m)-0.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 61.52
P/S 2.48
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-16.91
EYN/A
EPS(NY)3.18
Fwd EY1.63%
FCF(TTM)-14.51
FCFYN/A
OCF(TTM)-11.75
OCFYN/A
SpS78.95
BVpS-3.78
TBVpS-15.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.45%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 130.38%
Cap/Sales 3.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.37
Altman-Z 1.2
F-Score3
WACC9.88%
ROIC/WACCN/A
Cap/Depr(3y)90.02%
Cap/Depr(5y)74.76%
Cap/Sales(3y)2.43%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-247.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.64%
EPS Next Y91.1%
EPS Next 2Y47.72%
EPS Next 3Y32.64%
EPS Next 5Y20.17%
Revenue 1Y (TTM)-9.15%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%17.67%
Revenue Next Year25.38%
Revenue Next 2Y20.52%
Revenue Next 3Y17.13%
Revenue Next 5Y14.3%
EBIT growth 1Y-1098.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year149.79%
EBIT Next 3Y49.92%
EBIT Next 5Y32.37%
FCF growth 1Y-351.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-261.22%
OCF growth 3YN/A
OCF growth 5YN/A